William Blair & Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $290M | Sell |
1,334,109
-3,352
| -0.3% | -$744K | 0.83% | 23 |
|
|
2025
Q4 | $306M | Buy |
1,337,461
+73,880
| +6% | +$16.8M | 0.82% | 23 |
|
|
2025
Q3 | $293M | Buy |
1,263,581
+6,169
| +0.5% | +$1.26M | 0.78% | 26 |
|
|
2025
Q2 | $233M | Buy |
1,257,412
+14,307
| +1% | +$2.66M | 0.65% | 39 |
|
|
2025
Q1 | $260M | Buy |
1,243,105
+41,998
| +3% | +$8.16M | 0.79% | 26 |
|
|
2024
Q4 | $213M | Buy |
1,201,107
+29,771
| +3% | +$5.47M | 0.62% | 43 |
|
|
2024
Q3 | $231M | Buy |
1,171,336
+5,121
| +0.4% | +$956K | 0.68% | 34 |
|
|
2024
Q2 | $200M | Buy |
1,166,215
+28,273
| +2% | +$4.68M | 0.62% | 41 |
|
|
2024
Q1 | $207M | Buy |
1,137,942
+81,141
| +8% | +$14M | 0.65% | 37 |
|
|
2023
Q4 | $164M | Sell |
1,056,801
-13,140
| -1% | -$1.92M | 0.56% | 45 |
|
|
2023
Q3 | $159M | Sell |
1,069,941
-12,596
| -1% | -$1.85M | 0.61% | 39 |
|
|
2023
Q2 | $146M | Sell |
1,082,537
-73,092
| -6% | -$10.7M | 0.53% | 43 |
|
|
2023
Q1 | $184M | Sell |
1,155,629
-11,456
| -1% | -$1.75M | 0.74% | 31 |
|
|
2022
Q4 | $189M | Sell |
1,167,085
-31,282
| -3% | -$4.8M | 0.82% | 28 |
|
|
2022
Q3 | $161M | Buy |
1,198,367
+12,066
| +1% | +$1.73M | 0.74% | 32 |
|
|
2022
Q2 | $182M | Sell |
1,186,301
-10,982
| -0.9% | -$1.68M | 0.81% | 26 |
|
|
2022
Q1 | $194M | Sell |
1,197,283
-336
| -0% | -$48.8K | 0.68% | 31 |
|
|
2021
Q4 | $162M | Buy |
1,197,619
+83,386
| +7% | +$9.85M | 0.51% | 44 |
|
|
2021
Q3 | $120M | Sell |
1,114,233
-80,055
| -7% | -$9.15M | 0.41% | 54 |
|
|
2021
Q2 | $135M | Sell |
1,194,288
-23,935
| -2% | -$2.7M | 0.47% | 47 |
|
|
2021
Q1 | $132M | Buy |
1,218,223
+10,726
| +0.9% | +$1.15M | 0.5% | 45 |
|
|
2020
Q4 | $129M | Buy |
1,207,497
+73,096
| +6% | +$7.02M | 0.47% | 49 |
|
|
2020
Q3 | $99.4M | Buy |
1,134,401
+110,846
| +11% | +$10.4M | 0.42% | 53 |
|
|
2020
Q2 | $100M | Buy |
1,023,555
+94,490
| +10% | +$8.32M | 0.48% | 45 |
|
|
2020
Q1 | $70.8M | Buy |
929,065
+33,851
| +4% | +$2.88M | 0.44% | 54 |
|
|
2019
Q4 | $79.3M | Buy |
895,214
+69,365
| +8% | +$5.76M | 0.41% | 61 |
|
|
2019
Q3 | $62.5M | Buy |
825,849
+33,158
| +4% | +$2.27M | 0.36% | 67 |
|
|
2019
Q2 | $57.6M | Buy |
792,691
+14,194
| +2% | +$1.12M | 0.33% | 76 |
|
|
2019
Q1 | $62.7M | Sell |
778,497
-23,757
| -3% | -$1.94M | 0.38% | 71 |
|
|
2018
Q4 | $74M | Sell |
802,254
-365
| -0% | -$32.1K | 0.54% | 44 |
|
|
2018
Q3 | $75.9M | Buy |
802,619
+18,223
| +2% | +$1.73M | 0.47% | 52 |
|
|
2018
Q2 | $72.7M | Sell |
784,396
-15,217
| -2% | -$1.49M | 0.49% | 51 |
|
|
2018
Q1 | $75.7M | Sell |
799,613
-23,002
| -3% | -$2.53M | 0.54% | 47 |
|
|
2017
Q4 | $79.6M | Buy |
822,615
+8,163
| +1% | +$769K | 0.54% | 45 |
|
|
2017
Q3 | $72.4M | Buy |
814,452
+17,840
| +2% | +$1.36M | 0.54% | 46 |
|
|
2017
Q2 | $57.8M | Buy |
796,612
+38,894
| +5% | +$2.61M | 0.43% | 58 |
|
|
2017
Q1 | $47.9M | Buy |
757,718
+26,381
| +4% | +$1.66M | 0.39% | 70 |
|
|
2016
Q4 | $45.8M | Sell |
731,337
-21,499
| -3% | -$1.31M | 0.41% | 69 |
|
|
2016
Q3 | $47.5M | Sell |
752,836
-51,603
| -6% | -$3.34M | 0.42% | 70 |
|
|
2016
Q2 | $49.8M | Sell |
804,439
-4,406
| -0.5% | -$268K | 0.46% | 63 |
|
|
2016
Q1 | $46.2M | Buy |
808,845
+84,122
| +12% | +$4.69M | 0.43% | 70 |
|
|
2015
Q4 | $42.9M | Sell |
724,723
-90,914
| -11% | -$5.24M | 0.4% | 74 |
|
|
2015
Q3 | $44.4M | Sell |
815,637
-22,377
| -3% | -$1.46M | 0.38% | 78 |
|
|
2015
Q2 | $56.3M | Buy |
838,014
+78,765
| +10% | +$5.14M | 0.08% | 320 |
|
|
2015
Q1 | $44.4M | Sell |
759,249
-31,257
| -4% | -$1.89M | 0.07% | 351 |
|
|
2014
Q4 | $51.7M | Buy |
790,506
+11,662
| +1% | +$735K | 0.08% | 323 |
|
|
2014
Q3 | $45M | Sell |
778,844
-7,828
| -1% | -$435K | 0.08% | 337 |
|
|
2014
Q2 | $44.4M | Buy |
786,672
+24,932
| +3% | +$1.31M | 0.07% | 345 |
|
|
2014
Q1 | $39.2M | Sell |
761,740
-20,008
| -3% | -$1.01M | 0.06% | 373 |
|
|
2013
Q4 | $41.3M | Sell |
781,748
-48,921
| -6% | -$2.4M | 0.07% | 372 |
|
|
2013
Q3 | $37.2M | Buy |
830,669
+5,121
| +0.6% | +$227K | 0.07% | 397 |
|
|
2013
Q2 | $34.1M | Buy |
+825,548
| New | +$36.1M | 0.07% | 392 |
|
Other funds holding ABBV
VCM
VPM
William Blair & Company's ABBV Position: Q1 2026 in Review
William Blair & Company reduced its AbbVie (ABBV) stake by 0.25% in Q1 2026, selling an estimated $744K and leaving 1,334,109 shares worth $290M. The position accounts for 0.83% of the portfolio, ranked #23.
William Blair & Company first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $306M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- William Blair & Company held 1,334,109 shares of AbbVie worth $290M as of Q1 2026.
- William Blair & Company sold 3,352 AbbVie shares in Q1 2026, an estimated $744K.
- AbbVie made up 0.83% of William Blair & Company's portfolio in Q1 2026, its #23 holding.
- William Blair & Company first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- William Blair & Company's AbbVie position peaked at $306M in Q4 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.